Sarepta Therapeutics Inc (SRPT) — Capital Reinvestment Ratio
Sarepta Therapeutics Inc (SRPT) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow ($131.21 Million) in capital expenditures ($5.83 Million). See Sarepta Therapeutics Inc balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sarepta Therapeutics Inc Capital Reinvestment Ratio (2020–2020)
This chart tracks Sarepta Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check total reinvestment intensity of Sarepta Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Sarepta Therapeutics Inc (2020–2020)
Year-by-year Capital Reinvestment Ratio for Sarepta Therapeutics Inc from 2020 to 2020. For live market cap and broader valuation context, see SRPT market cap.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.76x | $107.47 Million | $82.20 Million | — |